当前位置:首页 - 行情中心 - 美康生物(300439) - 财务分析 - 现金流量表

美康生物

(300439)

  

流通市值:28.91亿  总市值:37.96亿
流通股本:2.92亿   总股本:3.84亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,309,426,445.1891,094,992.64388,623,587.911,466,908,974.91
  收到的税费返还5,190,807.492,362,271.88598,361.015,527,780.56
  收到其他与经营活动有关的现金29,206,383.0823,652,94511,927,770.1795,155,169.59
  经营活动现金流入小计1,343,823,635.67917,110,209.52401,149,719.091,567,591,925.06
  购买商品、接受劳务支付的现金792,159,569.15508,050,388.68260,140,790.01625,793,258.07
  支付给职工以及为职工支付的现金267,884,483.28191,454,989.06116,454,244.13368,107,760.72
  支付的各项税费73,263,603.3153,541,186.2828,261,825.0395,386,596.82
  支付其他与经营活动有关的现金160,157,843.63101,482,688.9554,117,111.26211,689,398.5
  经营活动现金流出小计1,293,465,499.37854,529,252.97458,973,970.431,300,977,014.11
  经营活动产生的现金流量净额50,358,136.362,580,956.55-57,824,251.34266,614,910.95
二、投资活动产生的现金流量:
  收回投资收到的现金1,086,864,670.24542,000,000205,000,000973,284,944.25
  取得投资收益收到的现金9,305,750.497,510,730.131,169,213.6321,217,025.97
  处置固定资产、无形资产和其他长期资产收回的现金净额25,00025,000-5,189,322.5
  处置子公司及其他营业单位收到的现金净额390,000390,000-363,080.44
  投资活动现金流入小计1,096,585,420.73549,925,730.13206,169,213.631,000,054,373.16
  购建固定资产、无形资产和其他长期资产支付的现金37,646,008.4824,984,160.3518,657,535.89191,407,877.19
  投资支付的现金1,394,400,000697,400,000195,288,0001,067,000,000
  投资活动现金流出小计1,432,046,008.48722,384,160.35213,945,535.891,258,407,877.19
  投资活动产生的现金流量净额-335,460,587.75-172,458,430.22-7,776,322.26-258,353,504.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金---2,694,000
  其中:子公司吸收少数股东投资收到的现金---480,000
  取得借款收到的现金60,000,00060,000,000-34,844,668.06
  收到其他与筹资活动有关的现金---0
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计60,000,00060,000,000-37,538,668.06
  偿还债务支付的现金20,000,00020,000,00020,000,00045,000,000
  分配股利、利润或偿付利息支付的现金12,894,865.387,571,400.2385,510.4751,992,779.54
  支付其他与筹资活动有关的现金11,019,997.89,495,734.85-17,258,666.61
  筹资活动现金流出小计43,914,863.1837,067,135.0820,085,510.47114,251,446.15
  筹资活动产生的现金流量净额16,085,136.8222,932,864.92-20,085,510.47-76,712,778.09
四、汇率变动对现金及现金等价物的影响-647,903.14-527,761.59-203,657.26-725,233.89
五、现金及现金等价物净增加额-269,665,217.77-87,472,370.34-85,889,741.33-69,176,605.06
  加:期初现金及现金等价物余额657,438,431.29657,438,431.29657,438,431.29726,615,036.35
  期末现金及现金等价物余额387,773,213.52569,966,060.95571,548,689.96657,438,431.29
补充资料:
  净利润-61,555,662.61-61,361,976.78
  资产减值准备-5,169,924.16-39,755,116.04
  固定资产和投资性房地产折旧-76,556,755.79-143,604,664.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-76,556,755.79-143,604,664.9
  无形资产摊销-7,756,850.59-14,273,559.95
  长期待摊费用摊销-6,980,134.81-13,070,723.67
  处置固定资产、无形资产和其他长期资产的损失--471.91--1,659,738.98
  固定资产报废损失-7,795.54-302,302.1
  公允价值变动损失--846,461.54--430,440.4
  财务费用-889,612.4-2,685,101.12
  投资损失--9,697,793.23--8,724,190.36
  递延所得税--2,863,445.23--31,091,798.66
  其中:递延所得税资产减少-1,351,827.02--11,815,798.23
    递延所得税负债增加--4,215,272.25--19,276,000.43
  存货的减少-3,182,745.15-33,853,414.88
  经营性应收项目的减少--37,146,200.19--64,039,601.58
  经营性应付项目的增加--55,206,605.21-41,606,677.94
  其他--135,535.64-7,133,388.68
  不涉及现金收支的投资和筹资活动金额其他项目---2,942,225.82
  现金的期末余额-569,966,060.95-657,438,431.29
  减:现金的期初余额-657,438,431.29-726,615,036.35
  现金及现金等价物的净增加额--87,472,370.34--69,176,605.06
公告日期2026-10-282026-08-292026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑